Evidence map›Paper›PMID 27942610›Full record

ArticleKidney international reports2016

SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL.

Bekir Tanriover, Malcolm P MacConmara, Justin Parekh, Cristina Arce, Song Zhang, Ang Gao, Arjmand Mufti, Swee-Ling Levea, Burhaneddin Sandikci, Mehmet U S Ayvaci and 6 more

Open access · goldAbstract read
In one paragraph

Article in Kidney international reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Simultaneous liver kidney allocation policy and the Safety Net: an early examination of utilization and outcomes in the United States.Transplant international : official journal of the European Society for Organ Transplantation · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Bekir TanrioverDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Malcolm P MacConmaraDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Justin ParekhDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Cristina ArceDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Song ZhangDepartment of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX.
Ang GaoDepartment of Clinical Sciences, UT Southwestern Medical Center, Dallas, TX.
Arjmand MuftiDigestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX.
Swee-Ling LeveaDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Burhaneddin SandikciBooth School of Business, University of Chicago, Chicago, IL.
Mehmet U S AyvaciInformation Systems, the University of Texas at Dallas, Dallas, TX.
Venketash K AriyamuthuDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Christine HwangDepartment of Surgery, UT Southwestern Medical Center, Dallas, TX.
Sumit MohanDivision of Nephrology, Columbia University, College of Physicians & Surgeons, New York, NY.
Mutlu MeteDepartment of Computer Science, Texas A&M, Commerce, TX.
Miguel A VazquezDivision of Nephrology, UT Southwestern Medical Center, Dallas, TX.
Jorge A MarreroDigestive and Liver Diseases, UT Southwestern Medical Center, Dallas, TX.
Southwestern Medical CenterThe University of Texas Southwestern Medical Center · USSouthwestern Medical Center · USColumbia University · USTexas A&M University – Commerce · USThe University of Texas at Dallas · USUniversity of Chicago · US

Funding

UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
NIDDK NIH HHS P30 DK079328
6 · The paper itself

Abstract

backgroundThe survival benefit from simultaneous liver-kidney transplantation (SLK) over liver transplant alone (LTA) in recipients with moderate renal dysfunction is not well understood. Moreover, the impact of deceased donor organ quality in SLK transplant survival has not been well described in the literature.

methodsThe Scientific Registry of Transplant Recipients was studied for adult recipients receiving LTA (N=2,700) or SLK (N=1,361) transplantation with moderate renal insufficiency between 2003 and 2013. The study cohort was stratified into four groups based on serum creatinine (Scr< 2 mg/dL versus Scr≥ 2 mg/dL) and dialysis status at listing and at transplant. The patients with end-stage renal disease and requiring acute dialysis more than three months before transplantation were excluded. A propensity score (PS)-matching was performed in each stratified groups to factor out imbalances between the SLK and LTA regarding covariates distribution and to reduce measured confounding. Donor quality was assessed with liver-donor risk index (L-DRI). The primary outcome of interest was post-transplant mortality.

resultsOn multivariable PS-matched Cox proportional hazard models, SLK led to decrease in post-transplant mortality compared to LTA across all four groups, but only reached statistical significance (HR 0.77; 95% CI, 0.62-0.96) in the recipients not exposed to dialysis and Scr≥ 2 mg/dL at transplant (mortality incidence rate per patient-year 5.7% in SLK vs. 7.6% in LTA, p=0.005). The decrease in mortality was observed among SLK recipients with better quality donors (L-DRI<1.5).

conclusionsExposure to pre-transplantation dialysis and donor quality affected overall survival among SLK recipients.

Identifiers

PMID27942610
PMCPMC5138564
OpenAlexW2476659492

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.